Frovatriptan Tablet, Film Coated
Product Images NDC 50742-299

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Frovatriptan (NDC 50742-299). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1 (0ab7825b C92c 45e2 Abaa Cb115564b312 01)

Chemical structure of frovatriptan succinate, the active ingredient in FROVATRIPTAN 2.5 mg film-coated tablets by Ingenus Pharmaceuticals, LLC. The diagram depicts the molecular arrangement including an indole core and succinate moiety with a water molecule.*

FDA Label Image

Image 2 (0ab7825b C92c 45e2 Abaa Cb115564b312 02)

A Kaplan-Meier plot showing the estimated probability of response over time from the initial dose in hours, comparing Placebo (dashed line) and Frovatriptan Succinate Tablets 2.5 mg (solid line). The graph illustrates higher response probability with Frovatriptan Succinate Tablets up to 2 hours post-dose.*

FDA Label Image

Image 3 (0ab7825b C92c 45e2 Abaa Cb115564b312 03)

A line graph comparing the estimated probability of remediation or rescue over 24 hours following the initial dose of Frovatriptan Succinate Tablets 2.5 mg versus placebo. The x-axis represents time from the initial dose in hours (0 to 24), and the y-axis shows the estimated probability in percentage (0% to 100%). Two lines depict the response: a solid line for Frovatriptan Succinate Tablets 2.5 mg and a dashed line for placebo.*

FDA Label Image

Image 4 (0ab7825b C92c 45e2 Abaa Cb115564b312 04)

FDA Label Image

Blister Label (0ab7825b C92c 45e2 Abaa Cb115564b312 05)

Frovatriptan succinate 2.5 mg base film-coated tablets packaging label with nine visible tablet compartments. Each compartment is marked with the drug name, strength, manufacturer (Ingenus Pharmaceuticals, LLC), and includes a barcode, lot, and expiration fields. The label specifies Rx Only and is designed for oral administration.*

FDA Label Image

Carton Label (0ab7825b C92c 45e2 Abaa Cb115564b312 06)

Packaging label for Frovatriptan Succinate Tablets 2.5 mg by Ingenus Pharmaceuticals, LLC. The label shows a white carton for a blister card containing 9 film-coated tablets. It includes dosage strength, NDC 50742-299-09, manufacturer details, storage instructions, and warnings to keep out of reach of children. The label also depicts two round tablets embossed with "ZNF" and "2.5."*

FDA Label Image

Image (0ab7825b C92c 45e2 Abaa Cb115564b312 113 2)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.